Tharimmune Files Additional Proxy Materials
Ticker: CNTN · Form: DEFA14A · Filed: May 2, 2025 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | DEFA14A |
| Filed Date | May 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy, filing-update, corporate-name-change
Related Tickers: THAR
TL;DR
THARIMMUNE (THAR) dropped extra proxy docs, formerly Hillstream BioPharma.
AI Summary
Tharimmune, Inc. filed a Definitive Additional Materials proxy statement on May 2, 2025. The filing relates to the company's proxy materials, indicating it is providing supplementary information to shareholders. Tharimmune, Inc. was formerly known as Hillstream BioPharma Inc. and changed its name on September 25, 2023.
Why It Matters
This filing provides shareholders with updated or supplementary information regarding proxy matters, which is crucial for informed voting decisions at shareholder meetings.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement supplement and does not contain new financial or strategic information that would inherently increase risk.
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- Hillstream BioPharma Inc. (company) — Former company name
- 20250502 (date) — Filing date
FAQ
What type of filing is this for Tharimmune, Inc.?
This is a Definitive Additional Materials proxy statement (DEFA14A).
When was this filing made?
The filing was made on May 2, 2025.
What was Tharimmune, Inc. previously named?
Tharimmune, Inc. was formerly known as Hillstream BioPharma Inc.
When did the company change its name from Hillstream BioPharma Inc.?
The company changed its name on September 25, 2023.
What is the primary business of Tharimmune, Inc.?
Tharimmune, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 2, 2025 regarding Tharimmune, Inc. (CNTN).